Join us for the 8th EMBO/FEBS lecture course on “Mitochondria in life, death and disease” – 16-20 September 2024, Landshut (Munich, GERMANY). Registration is open until 31 May 2024. #EMBOmitochondria #mito meetings.embo.org/event/24-mitoc…

For an overview of the role reactive oxygen species play in the regulation of mitochondrial activity and cytochrome c oxidase assembly, look no further than this #BiochemSocTrans mini-review from Erika Fdez-Vizarra and Povea-Cabello et al. doi.org/10.1042/BST202…

#YoInvestiguéSinCotizar durante mi tesis, donde empecé cobrando 100.000 pesetas (600 euros). Cómo voy a cotizar ahora 290 por mes???? #TimoConvenioSS

Two weeks left to register for the 8th EMBO/FEBS lecture course on “Mitochondria in life, death and disease” (16-20 September). Amazing line-up of speakers and many possibilities for early career scientists to discuss science and career paths. #EMBOmitochondria #mito

Currently reviewing a paper - It has 18 data dense figures (9 main, 9 supplemental). It's becoming very tricky to review papers as the sheer amount of time to assess the work appropriately is becoming unfeasible. It's also becoming an expectation to have such massive papers.

Curso El reto de la Atención Primaria en el Diagnóstico de las Enfermedades Mitocondriales #Sevilla #UPO #formación #enfermedadesmitocondriales

Happy to see our latest paper out today in Nucleic Acids Res. A beautiful collaboration with Annika Krüger, Joanna Rorbach Division of Molecular Metabolism, KI, Hana Antonicka and Eric Shoubridge. Antonio Barrientos ahram ahn bit.ly/3WyuPiE

Computer scientists fear that despite the incredible progress in AI and other fields there’ll never be a computer strong enough to smoothly run a Word document with lots of track changes

Our lab is super happy for having secured funding for the next 3 years! To study mito-cross talk in mitochondrial disease PID2023(Agencia Estatal de Investigación) and cancer (Emerxentes-Xunta de Galicia). Thanks to the MitoFitness Lab lab to make it possible! Recruitibg new PhD students soon! So get in touch!

Happy to share our Erika Fdez-Vizarra overview of the genetic basis and clinical features of complex III deficiency in The Journal of Inherited Metabolic Disease doi.org/10.1002/jimd.1…

New review: an update on the pathological variants in nuclear genes causing mitochondrial complex III deficiency. Kristyna Cunatova & Erika Fdez-Vizarra conclude that tissue specificity of complex III deficiency manifestations deserves to be investigated in the future. doi.org/10.1002/jimd.1…

Hablar en público es, según los expertos, una de las principales asignaturas pendientes de la educación en España. De hecho, siete de cada 10 universitarios lamenta no haber recibido formación para ello en ninguna de las etapas educativas elpais.com/educacion/2024…

This week, from Monday 16th to Sunday 22nd September 2024, E-mit raises awareness for World Mitochondrial Disease Week. E-mit supports all efforts to raise awareness & find a cure for mito disease. 💚 #WorldMitoWeek2024 #MitoAwareness See here for details: mitochondrialdiseaseweek.org

Fantastic talk today by Erika Fernandez-Vizarra Erika Fdez-Vizarra at the #EMBOmitochondria#mito meeting! EMBO/FEBS Lecture Course Mitochondria in life, death and disease!!👏🏽👏🏽👏🏽👇👇👇

Enjoying the 8th EMBO/FEBS lecture course on “Mitochondria in life, death and disease” organised by Nora Vögtle and Ricarda Richter-Dennerlein #EMBOmitochondria #mito meetings.embo.org/event/24-mitoc…

Amazing EMBO Women in Science Lecture by Alena Zikova about mitochondrial metabolic and structural remodelling in Trypanosoma! And Women in Science!

Happy to present our latest preprint. We identify adenylate kinase 2 as new interaction partner of apoptosis-inducing factor 1 (AIFM1) thereby linking AIFM1 to cellular metabolism and adaptation to fluctuating energy availability doi: doi.org/10.1101/2024.0…

I am editor in a journal. The last time a reviewer accepted my invitation to review was June 29. Currently, I have a ms with 22 invitations (I´ve had more), none accepted. Is it just me? Am I the only one reviewing ms for everyone else? (And yes, I came here to complain)